<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antibodies to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> (ACL) were detected in 12 (35%) of 34 patients with <z:e sem="disease" ids="C0919267" disease_type="Neoplastic Process" abbrv="">tumors of the ovaries</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>8 of 12 patients exhibited clinical signs of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, 9 (75%), 2 and 1 patients demonstrated isolated hyperproduction of IgG ACL, combined rise of IgG ACL and IgM ACL, IgM ACL, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Most frequently ACL occurred in <z:e sem="disease" ids="C0014175" disease_type="Disease or Syndrome" abbrv="">endometriosis</z:e> of the ovaries and <z:mpath ids='MPATH_305'>serous cystadenomas</z:mpath> (50 and 60%, respectively) </plain></SENT>
<SENT sid="3" pm="."><plain>In 5 (42%) of 12 patients CA-125 antigen concentration was above the upper norm (35 U/ml), in 3 (25%) cases the level of CA 19-9 antigen was elevated </plain></SENT>
<SENT sid="4" pm="."><plain>There were parallel changes of ACL concentration and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker CA-125 before and after operation </plain></SENT>
<SENT sid="5" pm="."><plain>Autoimmune origin of <z:e sem="disease" ids="C1335160" disease_type="Disease or Syndrome" abbrv="">ovarian endometriosis</z:e> is suggested </plain></SENT>
</text></document>